Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diebold, Incorporated
Diebold Reaches Agreement in Principle With SEC Staff
May 24th, 2009
Diebold, Incorporated (NYSE:DBD) has reached an agreement in principle with the staff of the Securities and Exchange Commission (SEC) to settle civil charges stemming from the staff's investigation. Diebold has also been informed by the United States Attorney's Office for the Northern District of Ohio that it will not bring criminal charges against the company in connection with the transactions and accounting issues that are the subject of the SEC investigation. Under the terms of the agreement in principle with the staff of the SEC, Diebold will neither admit nor deny civil securities fraud charges, will pay a penalty of $25 million and agree to an injunction against...
Source: Pharma Investments, Ventures & Law Weekly (2009-05-24)
|
